DUBAI INTERNATIONAL PHARMACEUTICALS TECHNOLOGIES CONFERENCE AND EXHIBITION

DUBAI, BAE, 2011

AND

Dubai Dubai (Arabic: Dubayy English pronunciation: /duːˈbaɪ/ doo-BY) is one of the seven emirates of the United Arab Emirates (UAE). It is located south of the Persian Gulf on the Arabian Peninsula and has the largest population with the second-largest land territory by area of all the emirates, after Abu Dhabi. Dubai and Abu Dhabi are the only two emirates to have veto power over critical matters of national importance in the country's legislature. “In the race for excellence, there is no finish line” - Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President and Prime Minister and the Ruler of Dubai. In sharp contrast to other neighbouring Islamic countries, Dubai has consistently encouraged an open-minded and open doors policy. While some of Dubai’s neighbouring countries do not allow women to be seen without her male escorts, Dubai presents a very progressive and liberal outlook. Women safely negotiate their way on Dubai’s roads even late at night without any eyebrows being raised. There is no dress code and tourists and residents are welcome to embrace any fashion as long as it does not offend anybody’s sensibilities. While oil has been crucial to Dubai’s development since the late 1960’s, the non-oil sector currently contributes more than 90 per cent of the total gross domestic product. Tourism, directly and indirectly adds up to 30 per cent of Dubai’s non-oil GDP while real estate and construction adds upto 19.4 per cent of the GDP. In business, the government of Dubai is dedicated to liberal and free market policies and to the creation of a business environment conducive to commercial activity. This is well illustrated by the incentives available to investors at the Dubai Airport Free Zone, Dubai Cars and Automotive Zone, the Gold and Diamond Park, Dubai Internet City, Dubai Media City and Jebel Ali Free Zone and also in the latest projects like the Dubai Healthcare City, Dubai International Financial Centre, Dubai Investments Park, Dubai Multi Commodities Centre, Dubai Silicon Oasis and the Mohammed bin Rashid Technology Park among others.

Dubai Health System Dubai Health has earned considerable international accreditation for its quality healthcare services, integrated medical education and research as well as spreading clinical awareness among general masses. The primary medical care and hospital facilities provided by Dubai Health are of very high standards and similar to those available in other parts of the world like USA and Western Europe. Dubai Health aims to concentrate more on the overall well-being of the countrymen. To this effect, the government-run medical centers and private health clinics existing around the city cater to the specific medical needs of both the residents and the expatriates living in the country. Attending the patients within the working hours as well as responding to postclinic private medical calls is a part of the responsibilities of the medical practitioners of Dubai Health system. The public hospitals are integral parts of the Dubai Health system, offering excellent medical facilities, especially during accidental injuries or other related emergencies. The indoor as well as the outdoor medical treatments available in these state-of-the-art equipped hospitals with highly trained staffs are reasonably prices, yet good and very useful for public welfare. A special feature of Dubai Health system is the superb network of medical shops located throughout the mainland area. The pharmacies located on every nook and corner of the streets are mostly wellstocked with both products available from the pharmaceutical companies as well as new medical brands emerging in the market. The staffs and salesmen working in some of these medical stores for years also sometimes provide useful health and medical advices to the visiting customers. The doctors in the Dubai Health system are mostly under the control of the Health Ministry in Dubai. Others come directly from the foreign lands like India, USA, Europe, Egypt and Pakistan and get their qualifications verified prior to practicing in this country. The successful amalgamation of both the national and international doctors promises the countrymen with high standards of treatment, which perhaps very few countries of the world is able to offer.

Overview         

UAE drug market expenditure was AED 2.17bn ($ 0.74bn) in 2007 which is expected to reach AED 4.13bn ($ 1.12bn) by the end of 2012 Pharmaceutical market has high growth potential due to stable and favourable regulatory and political environment in the UAE Increasing public and private wealth fuelled by the oil boom and strong healthcare infrastructure Establishment of Free Zones and a favourable investment climate to explore the emerging regional opportunities Drug consumption in the MENA region accounts for about 1.5% of the global total or around $ 9bn The UAE is 2nd in the region in terms of capital invested in the Pharma sector Reliant on imports with more than 72 countries exporting Pharma products to UAE Highest-priced market in the region The pharmaceutical industry in the UAE also benefits from re-export markets as Iran, Pakistan, Yemen and Somalia which are the major buyers of re-exported pharmaceuticals from the UAE

DUPHAT 2011 DUPHAT is the premier Pharmaceutical and Technology event in the Middle East launched in 1995 by INDEX® Conferences and Exhibitions Org. Est., a member of INDEX Holding in collaboration with the government through the Dubai Health Authority with the aim to provide a high-quality conference and a wide-ranging exhibition. The event is held under the patronage of H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance, UAE and President of Dubai Health Authority. DUPHAT 2011 – The 16th Dubai International Pharmaceuticals & Technologies Conference & Exhibition has developed to be one of the most recognized and significant pharmaceutical event in the Middle East and North Africa.

DUPHAT 2011 Conference Topics                            

Improving medicine use: System approach Community Pharmacy and Public Education Technology Driven Topical and Systemic Drug Delivery Systems Importance of Oncology Pharmacy in Chemotherapy Treatments, Are Residual Drugs Loss or Gain? The Pharmacist’s Role in Personalized Medicine Improving the safe use of medications in Gulf countries A New Accurate Method for Predicting Lithium Clearance and Daily Dosage Requirements in Adult Psychiatric Patients The Role of Pharmacists in Individualized Medicine: Evolving Science in Pharmaceutical Drug truth and the myth about Pharma R & D New Roles for Pharmacists – Barriers and Opportunities The Pharmacist’s Public Health Role The ASHP Pharmacy Practice Model Initiative The impact of pharmacist intervention on patients' adherence to antidepressant medication and patient-reported outcomes. Microneedle arrays: A new technology for improved transdermal drug delivery Automation Technologies and the Future of Pharmacy Practice A Trans-Disciplinary Approach to Evaluate Complex Decision-Making in Pharmacy Analysis of Intracellular Drug Concentrations: Immunosuppressives and Antiretrovirals Science vs. Marketing: The State of Relationships Between Healthcare Practitioners and Pharmaceutical Manufacturers in the United States Worksite Health and Productivity Management Development Of A Broad-Based Training Program To Upgrade Pharmacy Practice: A University Perspective Strategies for the Justification and Expansion of Clinical Pharmacy Services Implementation of a Robot for Chemotherapy Preparation Bridging Pharmacovigilance and Patient Safety The American Health Care System and health Care Reform Chemical Poisoning: An overview for health care professionals A New Approach To Continuing Professional Development How to establish Patient Counseling Services in your Pharmacy Strategic Planning For Hospital Pharmacy

              

Clinical Pharmacy – a Tool for Better Medicine Usage Pharmacogenomics and Personalized Medicine Measuring Patient Satisfaction. Why to do it and how? Justification and Implementation of Antimicrobial Steward Ship Programs Effective Patient Communication Techniques Stem Cells: A Primer for Pharmacists Health Risk Appraisal at the Worksite Optimizing your Pharmacy and Therapeutics Committee Strategy To Enhance Patients Adherence To Medication Research Methods Used to Assess Technological Changes in Pharmacy Practice Pharmaceutical Calculations for the Injectable Route Safe dispensing of Oral chemotherapy Drugs Toxicity and Safety Profile of OTC Products A Review of the Medical Errors, in Pharmaceutical and Health Care Services Globalization of clinical trials, scientific, regulatory and ethical challenges

ESOP in DUPHAT 2011 DAY 1 - 22 MARCH 2011 - Sheikh Rashid Hall B

SESSION 2 - Oncology Pharmacy | Chairperson: PROF. ISMAIL HEWALA 14:30 – 15:15

MSc.Ph. Ahmet Sami Bosnak,

Gaziantep University of Medical Faculty. Gaziantep Oncology Hospital, Gaziantep, Turkey

Importance of oncology pharmacy in chemotherapy treatments, are residual drugs loss or gain?

In 45-minutes presentation, at first, audience was informed about the concepts of Oncology Pharmacy, ESOP and Quapos. Subsequently, I explained the benefits of the central chemotherapy drug preparation units which will be established in hospitals. Using plenty of photographs, presentation viewed with caution. In the last part of the presentation, after the meeting held in Hamburg, ESOP opened its doors to international

membership. All the participating countries were invited to be an affiliated member of ESOP. At the end, question and answer section lasted about 30 minutes. Forwarded questions are:       

Is ESOP an organization of the European Union? Countries in Europe have very different economic levels, in this case how such Quapos standards can be applied? What about the costs of the centers for drug preparation units? What is the ratio between the residual drug’s costs and the cost of installation of a unit? How is the health policy in Turkey? Does Turkey, the state pays for all cancer treatments? What is your opinion? Is the stability of chemotherapy drugs according to the company information or to the active substance?

Interviewed important persons Prof. Randy P. Juhl, Ph.D. Vice Chancellor for Research Conduct and Compliance, Distinguished Service Professor of Pharmacy, University of Pittsburgh, USA Prof. Abdel Aziz Saleh, Ph.D. Former Deputy Regional Manager WHO/EMRO Dr. Kathryn R Schultz, Pharm.D., FASHP Director of Pharmacy - Bethesda Hospital, St Paul, USA Prof. Pierre Wallemacq, Ph.D., EurClin. Chem.Professor and Head of the Laboratory of Analytical BiochemistryCliniques Universitaires St Luc, Université Catholique de Louvain Brussels, Belgium

Prof. Hitoshi Sasaki, Ph.D. Director, Department of Hospital Pharmacy, Nagasaki University Hospital, Japan Prof. Bob Sindelar, Ph.D. Professor and Dean, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada Prof. M.Z. Younis, Ph.D. Tenured Professor of Health Economics & Finance, Jackson University, USA Prof. Emad ElAzazy, Pharm. D., Ph.D., CEO of Professional Pharma Inc. for Pharmaceutical Consulting Training & Quality Management, Consultant, Egyptian National Training Institute, Ministry of Health and population & Professional Secretary of EMRO Pharm. Forum, Egypt Dr. Joaquima Serradell, Pharm.D., Ph.D Research Associate, Pharmacy Department, Temple University Hospital, Philadelphia, USA Qadhi Saeed Al Murooshid Director General Dubai Health Authority Dubai - UAE Dr. Ali Al Sayed Hussain, MS, Ph.D. Chairman – DUPHAT 2011

Social Program Desert Safari on Day1,

Gala Dinner on Day 2, Al Murooj Rotana Hotel At Downtown Burj Khalifa while viewing the impressive Dubai Musical Fountain and Burj Khalifa.

Dinner Dhow Cruise on Day 3. I couldn’t attend because of my flight schedule.

At the end First, because of giving me this opportunity, I would like to thank the board directors of ESOP. Honestly, It was an excellent experience. Neighborhood and interest shown in me was really very nice. Dubai, other Asian and Middle Eastern countries, although their internal social problems, young population, and economic forces shaping the world of the future. European thinking about how he would save, Dubai thinking he spends. For several reasons, we must establish a link between these countries and ESOP. The proximity of the people in this area with the bridge, Turkey can play an important role because of his heritage. However, we must invite speakers from this side of the world. Yours, Ahmet Sami BOSNAK, Turkey Dekegate, ESOP,2011.